{
    "nctId": "NCT02505906",
    "briefTitle": "Late Toxicity in Breast Cancer Patients Treated With Breast-conserving Surgical Procedures and Radiotherapy Using the Simultaneous Integrated Boost Technique",
    "officialTitle": "N/A",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 5043,
    "primaryOutcomeMeasure": "Late radiation-induced toxicity (grade 2 or higher)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* WHO performance status 0-2.\n* Invasive breast cancer or ductal carcinoma in situ (DCIS).\n* Stage I-III breast cancer or DCIS.\n* Treated with curative radiotherapy of the breast (as part of breast conserving therapy) with simultaneous integrated boost technique, with or without irradiation of the regional (including internal mammary) lymph nodes.\n\nExclusion Criteria:\n\n* Previous thoracic radiotherapy.\n* Previous history of malignancy, except adequately treated carcinoma in situ of the cervix or basal cell carcinoma of the skin.\n* Bilateral (synchrone) invasive breast cancer.\n* Treatment prior to surgery (i.e. neoadjuvant chemotherapy, neoadjuvant hormonal therapy, pre-operative radiotherapy).\n* Distant metastases at diagnosis (M1).\n* Unsufficient knowledge of Dutch language.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}